Pivotal Bio Venture Partners Investment Advisor LLC Arcutis Biotherapeutics, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $127 Million
- Q3 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 2,120,508 shares of ARQT stock, worth $29.9 Million. This represents 15.54% of its overall portfolio holdings.
Number of Shares
2,120,508
Previous 2,041,108
3.89%
Holding current value
$29.9 Million
Previous $19 Million
3.89%
% of portfolio
15.54%
Previous 17.1%
Shares
7 transactions
Others Institutions Holding ARQT
# of Institutions
197Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC11.7MShares$165 Million0.07% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$155 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$151 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$124 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$122 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $849M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...